Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors.

Seminars in arthritis and rheumatism·2025

Same author

Do national health priorities align with Global Burden of Disease estimates on disease burden? An analysis of national health plans and official governmental websites.

Public health·2023

Same author

Re: can modifications to how medical imaging findings are reported improve quality of care? A systematic review. A reply.

Clinical radiology·2022

Same author

Can modifications to how medical imaging findings are reported improve quality of care? A systematic review.

Clinical radiology·2022

Same author

What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies.

Journal of internal medicine·2020

Same author

Use of The Global Alliance for Musculoskeletal Health survey module for estimating the population prevalence of musculoskeletal pain: findings from the Solomon Islands.

BMC musculoskeletal disorders·2018

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Oral steroids for adhesive capsulitis.

R Buchbinder¹, S Green, J M Youd

¹Cabrini Hospital and Monash Unversity, Department of Clinical Epidemiology, Suite 41, Cabrini Medical Centre, 183 Wattletree Rd, Malvern, Victoria, Australia. rachelle.buchbinder@med.monash.edu.au

The Cochrane Database of Systematic Reviews

|October 21, 2006

Summary

Oral steroids offer short-term relief for adhesive capsulitis (frozen shoulder) pain and stiffness. However, benefits in shoulder function and range of motion may not last beyond six weeks.

More Related Videos

Rat Model of Adhesive Capsulitis of the Shoulder

Rat Model of Adhesive Capsulitis of the Shoulder

Published on: September 28, 2018

Related Experiment Videos

Last Updated: Jul 19, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Rat Model of Adhesive Capsulitis of the Shoulder

Rat Model of Adhesive Capsulitis of the Shoulder

Published on: September 28, 2018

Area of Science:

Orthopedics
Rheumatology
Pharmacology

Background:

Adhesive capsulitis, commonly known as frozen shoulder, is a painful and debilitating condition affecting shoulder mobility.
Interventions for shoulder pain are a focus of Cochrane reviews, aiming to provide evidence-based guidance.

Purpose of the Study:

To evaluate the efficacy and safety of oral steroid medications for treating adhesive capsulitis.
To synthesize findings from randomized controlled trials comparing oral steroids to placebo or other treatments.

Main Methods:

Systematic review of randomized controlled trials (RCTs) identified through comprehensive database searches (Cochrane Library, MEDLINE, EMBASE, CINAHL) up to November 2005.
Inclusion criteria focused on RCTs involving participants with adhesive capsulitis and interventions with oral steroids versus control groups (placebo, no treatment, or other interventions).
Methodological quality assessment and data extraction were performed by two independent reviewers using standard Cochrane methodology.

Main Results:

Five small RCTs were included, varying in design, comparators, and oral steroid regimens.
One trial showed significant short-term benefits of oral steroids over placebo for pain, shoulder abduction, and function (SPADI score), but these were not sustained at six weeks.
Other trials reported no significant differences or only rapid initial pain improvement compared to placebo or no treatment, with minimal adverse effects.

Conclusions:

"Silver" level evidence suggests oral steroids provide significant short-term improvements in pain, range of motion, and function for adhesive capsulitis.
The therapeutic effects of oral steroids may diminish after six weeks, indicating a limited duration of benefit.
Further high-quality research is needed due to the variable quality and reporting of included trials.